sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Holdings in Mural Oncology PLC
The Vanguard Group, Inc. has disclosed its position in Mural Oncology PLC through a Form 8.3 filing with the Irish Takeover Panel. As of June 9, 2025, Vanguard controls 772,915 ordinary shares of Mural Oncology, representing 4.48% of the company's relevant securities. This disclosure is in line with Rule 8.3 of the Irish Takeover Panel Act, applicable to entities holding 1% or more of the relevant securities.
No additional parties related to the offer are disclosed by Vanguard, and there are no other interests or short positions outside this tranche. Recent transactions involve purchasing 80 shares and selling 32 shares, both at a price of 2.61 USD per share. Furthermore, there are no cash-settled or stock-settled derivative transactions disclosed, nor are there agreements or understandings related to options or derivatives.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.